SUPN R&D Expense Growth
Supernus Pharmaceuticals Inc · R&D Expense Growth
SUPN R&D Expense Growth
Latest reported-2.35%period ending
SUPN FY R&D Growth (YoY) (0.00% → -2.35%)
Latest values, visible window
High-resolution chart · PNG
SUPN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -2.3539% | |
| 18.782% | |
| 22.8579% | |
| -17.5921% | |
| 19.0966% | |
| 9.9307% | |
| -22.5426% | |
| 79.9403% | |
| 15.8585% | |
| 46.8715% | |
| 48.7542% | |
| 13.5749% | |
| -26.6701% | |
| -23.2148% | |
| -12.8652% | |
| 20.1265% | |
| -3.9491% | |
| 58.0953% | |
| 0% |